Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cyclophosphamide (cytoxan) (1 trial)
dactinomycin (cosmegen) (1 trial)
gemcitabine (gemzar) (1 trial)
paclitaxel (taxol) (1 trial)
vincristine (oncovin) (1 trial)
vinorelbine (navelbine) (1 trial)
autologous hematopoietic stem cells (1 trial)
sargramostim (leukine) (1 trial)
temozolomide (temodar) (1 trial)
Tetanus and diphtheria toxoids adsorbed (Decavac) (1 trial)
ttrna-dcs (1 trial)
ttrna-xalt (1 trial)
Glioma (Phase 1)
Osteosarcoma (Phase 2)
Rhabdomyosarcoma (Phase 2)
Sarcoma (Phase 2)
Sarcoma, Ewing (Phase 2)
Trials (3 total)
Trial APIs (12 total)